Zura Bio Overview
Zura Bio (ZURA) has a ROE of -59.08%, below the sector sector average of -5.68%.
Get informed when a big investor buys or sells
+ Follow-59.08%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for ZURA is -59.08%. That is below the sector sector average of -5.68%. Investors often review this figure alongside Zura Bio's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, ZURA currently prints -59.08% for ROE, while the sector average sits near -5.68%. That is roughly 939.6% below the sector mean. Large gaps often invite a closer look at Zura Bio's growth, margins, and balance sheet.
Return on Equity shows how effectively Zura Bio converts resources into returns. At -59.08%, ZURA may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ZURA's ROE (-59.08%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
